Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment
Clinical trial NCT04174859 · COMPLETED
Trial details
- NCT number
- NCT04174859
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-10
- Primary completion
- 2022-06-30
- Enrollment
- 812
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.